A RANDOMIZED TRIAL - INTENSIVE TREATMENT BASED IN IVERMECTIN AND IOTA-CARRAGEENAN AS PRE-EXPOSURE PROPHYLAXIS FOR COVID- 19 IN HEALTHCARE AGENTS
Rossana Elena Chahla, Luis Medina Ruiz, Eugenia Silvana Ortega, Marcelo Fabio Morales, Francisco Barreiro, Alexia George, Cesar Mancilla, Sylvia Paola D’ Amato, Guillermo Barrenechea, Daniel Gustavo Goroso, Maria de los Angeles Peral de Bruno
doi: https://doi.org/10.1101/2021.03.26.21254398
Rossana Elena Chahla
1Head SI.PRO.SA (Province Health System), Ministry of Health, Tucumán, Argentina
Luis Medina Ruiz
2President of the Medical Executive Secretary, SI.PRO.SA Tucumán, Argentina
Eugenia Silvana Ortega
3Health Research Institute, Ministry of Health, SI.PRO.SA, Tucumán, Argentina
Marcelo Fabio Morales
4Clinical Hospital “Angel C. Padilla”, Tucumán, Argentina
Francisco Barreiro
5Medical Center Emergence, Tucumán, Argentina
Alexia George
5Medical Center Emergence, Tucumán, Argentina
Cesar Mancilla
4Clinical Hospital “Angel C. Padilla”, Tucumán, Argentina
Sylvia Paola D’ Amato
4Clinical Hospital “Angel C. Padilla”, Tucumán, Argentina
Guillermo Barrenechea
3Health Research Institute, Ministry of Health, SI.PRO.SA, Tucumán, Argentina
Daniel Gustavo Goroso
6Research and Technology Center, Mogi das Cruzes University, Brazil., Human Motor Skill Analysis Laboratory, National University of Tucumán, Tucumán, Argentina
Maria de los Angeles Peral de Bruno
3Health Research Institute, Ministry of Health, SI.PRO.SA, Tucumán, Argentina
Data Availability
We put at disposal the data used for those who request them
Posted March 30, 2021.
A RANDOMIZED TRIAL - INTENSIVE TREATMENT BASED IN IVERMECTIN AND IOTA-CARRAGEENAN AS PRE-EXPOSURE PROPHYLAXIS FOR COVID- 19 IN HEALTHCARE AGENTS
Rossana Elena Chahla, Luis Medina Ruiz, Eugenia Silvana Ortega, Marcelo Fabio Morales, Francisco Barreiro, Alexia George, Cesar Mancilla, Sylvia Paola D’ Amato, Guillermo Barrenechea, Daniel Gustavo Goroso, Maria de los Angeles Peral de Bruno
medRxiv 2021.03.26.21254398; doi: https://doi.org/10.1101/2021.03.26.21254398
A RANDOMIZED TRIAL - INTENSIVE TREATMENT BASED IN IVERMECTIN AND IOTA-CARRAGEENAN AS PRE-EXPOSURE PROPHYLAXIS FOR COVID- 19 IN HEALTHCARE AGENTS
Rossana Elena Chahla, Luis Medina Ruiz, Eugenia Silvana Ortega, Marcelo Fabio Morales, Francisco Barreiro, Alexia George, Cesar Mancilla, Sylvia Paola D’ Amato, Guillermo Barrenechea, Daniel Gustavo Goroso, Maria de los Angeles Peral de Bruno
medRxiv 2021.03.26.21254398; doi: https://doi.org/10.1101/2021.03.26.21254398
Subject Area
Subject Areas
- Addiction Medicine (381)
- Allergy and Immunology (699)
- Anesthesia (189)
- Cardiovascular Medicine (2832)
- Dermatology (242)
- Emergency Medicine (427)
- Epidemiology (12531)
- Forensic Medicine (10)
- Gastroenterology (799)
- Genetic and Genomic Medicine (4407)
- Geriatric Medicine (400)
- Health Economics (712)
- Health Informatics (2837)
- Health Policy (1045)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (114)
- Nephrology (460)
- Neurology (4167)
- Nursing (220)
- Nutrition (615)
- Oncology (2194)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (316)
- Pain Medicine (265)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1169)
- Primary Care Research (481)
- Public and Global Health (6752)
- Radiology and Imaging (1484)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (365)
- Surgery (471)
- Toxicology (57)
- Transplantation (200)
- Urology (173)